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Abstract
Despite the fact that there are more than twenty thousand biomedical journals in the world, research into the work of editors and publication pro-
cess in biomedical and health care journals is rare. In December 2012, the Esteve Foundation, a non-profit scientific institution that fosters progress 
in pharmacotherapy by means of scientific communication and discussion organized a discussion group of 7 editors and/or experts in peer review 
biomedical publishing. They presented findings of past editorial research, discussed the lack of competitive funding schemes and specialized jour-
nals for dissemination of editorial research, and reported on the great diversity of misconduct and conflict of interest policies, as well as adherence 
to reporting guidelines. Furthermore, they reported on the reluctance of editors to investigate allegations of misconduct or increase the level of data 
sharing in health research. In the end, they concluded that if editors are to remain gatekeepers of scientific knowledge they should reaffirm their 
focus on the integrity of the scientific record and completeness of the data they publish. Additionally, more research should be undertaken to under-
stand why many journals are not adhering to editorial standards, and what obstacles editors face when engaging in editorial research.
Key words: editorial policies; periodicals as topic; peer review; authorship; conflict of interest
Received: March 26, 2014 Accepted: May 19, 2014
Editorial research and the publication process in biomedicine and health: 
Report from the Esteve Foundation Discussion Group, December 2012
Ana Marušić*1, Mario Malički1, Erik von Elm2 for The Esteve Foundation Discussion Group3
1Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia
2Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland
3Participants in the Discussion Group: Xavier Bosch (Department of Internal Medicine, Hospital Clinic, University of Barcelona, 
Barcelona, Spain), Erik von Elm (Lausanne University Hospital, Lausanne, Switzerland), Annette Flanagin (JAMA, Chicago, Illinois, 
USA), Peter Gøtzsche (The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark), Harvey Marcovitch (Committee on 
Publication Ethics), Ana Marušić and Mario Malički (University of Split School of Medicine, Split, Croatia) and David L. Schriger 
(Department of Emergency Medicine, School of Medicine, University of California, Los Angeles, USA). Fèlix Bosch attended the 
meeting as Director of the Esteve Foundation (Barcelona, Spain)
*Corresponding author: ana.marusic@mefst.hr
Research integrity corner
Introduction
Journal editors have various tasks and responsibili-
ties: from defining submission, peer review and 
disseminating processes, selecting articles to be 
published, contributing editorial pieces, dealing 
with scientific misconduct, providing leadership 
and editorial team management, and ultimately 
raising standards in methodological rigor, scientif-
ic reporting and public knowledge. They also face 
numerous challenges, particularly in ensuring the 
integrity of the published records, such as publica-
tion misconduct. Some of these issues have been 
addressed by the policies and guidelines of edito-
rial organizations such as the World Association of 
Medical Editors (WAME), International Committee 
of Medical Journal Editors (ICMJE), Committee on 
Publication Ethics (COPE) and Council of Science 
Editors (CSE). Yet, despite an estimated number of 
more than twenty thousand journals (and thus 
many more editors) in the world, research into the 
work of editors and the publication process in bio-
medical and health care research is quite rare.
On the 12th and 13th December 2012 in Barcelona, 
an invitation-only Esteve Foundation Discussion 
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Group was organized by the Esteve Foundation, a 
non-profit scientific institution whose primary goal 
is to foster progress in pharmacotherapy by means 
of scientific communication and discussion. The 
goal of the discussion group was to examine cur-
rent editorial research in biomedicine and make 
recommendations for its future.
Plenary presentations
The two day discussion started with a presenta-
tion by Ana Marušić, editor in chief of the Journal 
of Global Health, vice president of the European 
Association of Science Editors (EASE) and former 
president of WAME and CSE. She elaborated on 
terms indexed by the National Library of Medicine 
(NLM) through the Medical Subject Headings 
(MeSH) thesaurus. These terms present concepts 
in medicine, which are then used to find evidence 
for research and practical questions in biomedi-
cine (1,2). Mapping of key concepts in editorial re-
search, such as journal, impact factor, publishing, 
peer review, and authorship, is rather incomplete 
and often only a recent addition to the MeSH. Most 
of these concepts are categorized within informa-
tion sciences, but some do not match their current 
use in health research. A good example is the defi-
nition of authorship. Whereas MeSH defines the 
concept of authorship as: “The profession of writ-
ing. Also the identity of the writer as the creator of 
a literary production.”; the current ICMJE guide-
lines specifically address four qualifying criteria re-
lated to research, writing, approval of the manu-
script and accountability for the work (3). Prof. 
Marušić also pointed out that several general and 
specialty journals publish articles on editorial re-
search (often called ‘peer review’ or ‘publication 
research’) but, to date, no journal fully specializes 
in this research field. Likewise, the funding oppor-
tunities for editorial research are scarce.
Annette Flanagin, executive managing editor of 
JAMA (Journal of the American Medical Associa-
tion) and coordinator of the International Congress 
on Peer Review and Biomedical Publication, re-
ported on some of the groundbreaking research 
presented at the past six Peer Review Congresses 
and described its origins. Drummond Rennie, 
JAMA editor and director of the Peer Review Con-
gresses, has initiated and led the effort to put peer 
review and other methods of assessment in bio-
medical research under the same level of scrutiny 
that journals and editors demand of science itself. 
Since 1989, the quadrennial Peer Review Congress-
es have encouraged and provided a forum for re-
search into all aspects of the biomedical research 
dissemination enterprise, including research into 
management and reporting of bias, transparency 
of research reporting, authorship and contributor-
ship, peer review, editorial evaluation, and dissem-
ination of biomedical information (4).
Xavier Bosch, consultant internist at the Hospital 
Clinic of Barcelona and researcher in peer review, 
reflected on the scale of scientific misconduct in 
biomedicine, means of dealing with it and the 
journals’ role in promoting research integrity. In a 
survey of 41 journals which published retractions 
or corrections due to scientific misconduct from 
1992 to 1999 only 14% addressed scientific mis-
conduct in their instructions to authors (5). Of 50 
high-profile biomedical journals surveyed in 2006, 
only 7 (14%) had written and publicly available 
misconduct policies (6). In 2009, a survey of 197 
editors of randomly chosen journals showed that 
94 (48%) journals had a written policy, of which 53 
(56%) were policies of the publishers (7). Addition-
ally, of 399 top-ranked journals, 140 (35%) had ex-
plicit definition of misconduct, 143 (36%) used pol-
icies of the publishers, and another 124 (31%) 
adopted them from policy-producing bodies. A 
total of 112 (28%) journals used plagiarism-check-
ing services (8).
Erik von Elm, senior epidemiologist at the Institute 
of Social and Preventive Medicine in Lausanne, 
Switzerland, co-director of Cochrane Switzerland, 
and Academic Editor of PLoS ONE presented evi-
dence on journals’ endorsement of recommenda-
tions aimed at improving publication practice. 
Several surveys of paediatric, haematology and 
urology journals showed that about 60% of jour-
nals direct their submitting authors to the Recom-
mendations for the Conduct, Reporting, Editing 
and Publication of Scholarly Work in Medical Jour-
nals (formerly, Uniform Requirements), published 
by the International Committee of Medical Journal 
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Editors (ICMJE) (3). About 35% required that trials 
reported in submitted manuscripts had been pre-
viously registered. 70% of journals had conflict of 
interest policies but only 24% recommend use of 
any reporting guidelines (9-13). These numbers 
demonstrate that more efforts are needed to im-
prove endorsement of such recommendations. In 
turn, more accurate and complete reporting of pri-
mary studies would enable their inclusion in sys-
tematic reviews and, thus, potentially contribute 
to improvements in health care.
Peter Gøtzsche, professor of Clinical Research De-
sign and Analysis, and Director of The Nordic Co-
chrane Centre in Copenhagen, Denmark, reflected 
on the accountability, transparency and honesty 
in the medical sciences. He called for a revolution 
in scientific research and reporting, and empha-
sised that too many published papers serve no 
one but the authors or sponsors, with a large 
number of papers being biased or superfluous and 
therefore unusable for furthering of public knowl-
edge. He also stressed that anonymised raw pa-
tient-level data, alongside research protocols and 
amendments, needs to be made publicly available 
for independent research and scrutiny, and this 
practice enforced by legislations (14).
David L. Schriger, professor of emergency medi-
cine at the University of California, Los Angeles, 
USA, and deputy editor of Annals of Emergency 
Medicine, discussed current peer review practices. 
While peer reviewers are typically given specific 
instructions on the format of their review, they are 
often not told the main purpose of their task. Most 
likely, editors also lack a clear view on whether re-
viewers are being asked to sort the true from the 
non-true, or if their primary job is to ensure that 
the paper contains sufficient information to allow 
readers to decide whether they agree with the au-
thors’ conclusion, a state Ziman termed consensi-
bility (15). The current focus on methodological 
rigor may make reviewers believe that their prima-
ry task is to determine validity but this can be a 
dangerous practice, e.g. in the case of Helicobacter 
discovery, which would later be awarded the No-
bel Prize in Medicine, editors of Lancet were una-
ble to find reviewers who believed the study find-
ings (16). An argument can therefore be made that 
the main focus of peer review is to ensure that the 
work is complete and clear so that the scientific 
community can judge its validity. Similarly, in keep-
ing with the focus on methodological rigor, most 
reporting guidelines emphasize the reporting of 
methods, giving less attention to the means of re-
porting results. Measures such as enhanced access 
to datasets, use of improved graphics and liberal 
use of electronic supplementary data tables and 
figures, can provide readers with a more compre-
hensive view of published research findings.
Harvey Marcovitch, former chairman of COPE, as-
sociate editor of the British Medical Journal, and a 
former Board Director of CSE, reported on retrac-
tions of publications and pressures faced by edi-
tors. From 2000 to 2010 there has been an increase 
in the number of retracted publications in bio-
medicine (17). Research on 2047 retracted articles 
indexed by PubMed showed that most (67%) were 
retracted due to misconduct (18). There is also evi-
dence from individual cases that editors ignore 
suspicions of fraud and fail to properly investigate 
matters, even after receiving support by organiza-
tions such as COPE. As membership in COPE is op-
tional, legislative or other measures are needed to 
deal with and prevent scientific misconduct.
Specific discussion and 
recommendations
Following each of the plenary lectures, many ques-
tions were raised, discussed and some solutions 
for the existing problems proposed. In the final 
session and through input provided one week af-
ter the meeting, several key topics and recommen-
dations emerged.
Guidelines for editors
There is considerable heterogeneity in funding, 
experience and tradition of large and small jour-
nals, as well as those in different countries and 
fields. This requires broader editorial guidelines 
that would cover the whole spectrum of editorial 
endeavour, and include sections on means to ob-
tain indexation of journals in bibliographic and ci-
tation databases, as well as methods of screening 
for duplicate or plagiarized research. As many edi-
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tors of academic and scholarly journals are re-
searchers themselves and may publish in journals 
they edit (19), clear guidelines and editorial proc-
esses need to be established and made transpar-
ent to tackle this specific conflict of interest. Like-
wise, existing guidelines for editors need to be 
made more visible and their effectiveness ap-
praised.
Editorial research
Depending on the available resources, contract 
agreements, publisher dependence, and level of 
interest, editors differ in the amount of time they 
dedicate to editorial research. On a larger scale, 
many aspects of editorial work thus remain un-
known, including more precise estimates of key 
editorial practices such as rejection rates, propor-
tion of manuscripts sent for review and changes 
that occur following peer review. In order to en-
courage more editors and independent research-
ers to become involved in editorial research, and 
especially in multi-journal collaborations, it is criti-
cal that publishers and funders recognize the im-
portance of this research field and establish fund-
ing schemes that would both sustain and increase 
editorial research competitiveness, as well as its 
quality. Likewise, additions and re-definitions of 
key concepts of editorial research in MeSH are 
needed to increase the field’s visibility.
Need for policy change
Initiatives of individual journals and editorial 
groups alone are probably insufficient to bring 
about necessary changes in reporting, availability 
and accessibility of scientific research and data. 
Legislative actions, similar to those of the Research 
Councils’ Policy on Open Access and Supporting 
Guidance in the UK (20), and the proposed Fair Ac-
cess to Science and Technology Research Act in 
the USA (21), would not only secure open accessi-
bility of all research involving humans, but also es-
tablish, promote and monitor quality standards of 
scientific reporting. Ethical and institutional boards 
need to play a more proactive role in monitoring 
research they approve by requiring project up-
dates or milestone reports. Study protocols of all 
types of research should be made available either 
through institutional boards or publicly accessible 
registries. These databases should allow for sub-
mission of raw data, within a fixed timeframe fol-
lowing the studies completion, and in that way 
prevent instances of non-publication or partial 
publication and unavailability of data from public-
ly or industry funded human research. Educational 
courses on research methodology, statistics and 
scientific reporting, complemented by courses on 
scientific integrity, should be mandatory in gradu-
ate curriculums. And lastly, a part of a research 
grant should be reserved exclusively for publica-
tion purposes, depositing raw data in an easily an-
alyzable format, and possibly for adherence to re-
porting guidelines.
Collaborating to improve peer review
Knowledge, experience and practice from editorial 
research in biomedicine and health research 
should be disseminated to other fields and vice 
versa. To reduce wasteful use of resources, peer re-
view reports of manuscripts submitted but not ac-
cepted for publication could be made available 
through journal websites or specific databases to 
help and enable editors of other journals to make 
better informed decisions. This might also prevent 
instances in which authors submit unfinished 
manuscripts and abuse a journal’s peer review 
process as a means of assistance with writing (or 
polishing) their papers.
Letters to the editor and post publication peer 
review
A crucial component of scholarly publishing, and 
science in general, is debate. However, many jour-
nals impose stringent word limits and short sub-
mission periods for letters to the editors in re-
sponse to published articles (22). To provide op-
portunities for debate, electronic means for com-
menting and reviewing published articles have 
been introduced by some journals (e.g. BMJ or 
Pediatrics), but smaller journals may not have the 
resources to do so. For online post-publication 
peer review to be useful, effective models of its 
moderation and linkage to literature databases 
need to be developed.
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Conclusion
Editors today should reaffirm their focus on the in-
tegrity and completeness of the data they publish. 
Several initiatives and instruments exist to help 
them with this endeavour, but additional efforts 
are needed to make them known, in particular to 
editors of regional and newly established journals. 
Initiatives of individual journals, e.g. publication of 
submitted manuscripts alongside peer review 
comments and final versions, demonstrate that in-
novative procedures are feasible, at least at small 
scale. However, without changes in policy, either 
state or inter-journal, these initiatives remain only 
perks of individual journals. More research is need-
ed to better understand critical questions such as 
why many journals are reluctant to use reporting 
guidelines or checklists, or to react adamantly to 
improperly published papers (23). Furthermore, 
better identification of actors and stakeholders of 
editorial research is needed, including identifica-
tion of obstacles editors face when engaging in 
editorial research, and incentives that are or should 
be in place in order for them to do so. In the fast 
changing world of biomedical publishing, editorial 
research could play an essential role in identifying 
the changes that are needed and viable if editors 
are to remain gatekeepers of scientific knowledge.
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